Simplex Trading
GYRE icon

Simplex Trading’s Gyre Therapeutics GYRE Stock Holding History

Simplex Trading’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-313
Closed -$2K – 9197
2023
Q3 		$2K Buy
313
+6
+2% +$40 ﹤0.01% 8100
2023
Q2 		$1K Buy
+307
New +$1.1K ﹤0.01% 8624
2023
Q1 		– Sell
-34,347
Closed -$135K – 9435
2022
Q4 		$135K Sell
34,347
-23,680
-41% -$96.6K ﹤0.01% 4714
2022
Q3 		$219K Buy
58,027
+17,307
+43% +$220K ﹤0.01% 4493
2022
Q2 		$543K Buy
40,720
+26,907
+195% +$179K ﹤0.01% 3339
2022
Q1 		$68K Buy
13,813
+13,466
+3,881% +$66.7K ﹤0.01% 6688
2021
Q4 		$2K Sell
347
-7,520
-96% -$129K ﹤0.01% 9991
2021
Q3 		$256K Hold
7,867
– – ﹤0.01% 5185
2021
Q2 		$255K Buy
7,867
+7,701
+4,639% +$264K ﹤0.01% 5269
2021
Q1 		$627K Buy
166
+160
+2,667% +$7.31K ﹤0.01% 3032
2020
Q4 		$28K Sell
6
-4
-40% -$173 ﹤0.01% 6719
2020
Q3 		$30K Buy
+10
New +$391 ﹤0.01% 6065
2020
Q2 		– Sell
-1
Closed -$2K – 7879
2020
Q1 		$2K Sell
1
-5
-83% -$230 ﹤0.01% 7186
2019
Q4 		$32K Buy
+6
New +$251 ﹤0.01% 5597
2019
Q3 		– Sell
-1
Closed -$7K – 7483
2019
Q2 		$7K Sell
1
-14
-93% -$875 ﹤0.01% 6291
2019
Q1 		$93K Buy
15
+14
+1,400% +$900 ﹤0.01% 4410
2018
Q4 		$6K Sell
1
-13
-93% -$959 ﹤0.01% 6128
2018
Q3 		$113K Buy
14
+2
+17% +$158 ﹤0.01% 4315
2018
Q2 		$103K Buy
+12
New +$2.1K ﹤0.01% 4251
2017
Q2 		– Sell
-12
Closed -$47K – 6360
2017
Q1 		$47K Buy
+12
New +$701 ﹤0.01% 2428

Other funds holding GYRE

HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Simplex Trading's GYRE Position: Q2 2026 in Review

Simplex Trading sold out of Gyre Therapeutics (GYRE) in Q2 2026, closing a stake of 674 shares — an estimated $4.7K sold.

Simplex Trading first reported a position in GYRE in Q1 2015 and held it in 18 quarters. The position peaked at $492K in Q2 2018. 60 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

  • Simplex Trading reported no remaining Gyre Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 674 Gyre Therapeutics shares in Q2 2026, an estimated $4.7K.
  • Simplex Trading first reported a position in Gyre Therapeutics in Q1 2015 and held it in 18 quarters.
  • Simplex Trading's Gyre Therapeutics position peaked at $492K in Q2 2018.
  • 60 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.